GLMD
Galmed Pharmaceuticals Ltd
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.63
-0.02 ▼ -3.20%
🌙 3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.63
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -3.53 | Insider Own | 1.19% | Shs Outstand | 0.01B | Perf Week | -4.55% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.01B | Perf Month | -5.56% |
| Enterprise Value | -0.02B | PEG | - | EPS next Q | - | Inst Own | 7.21% | Short Float | 0.5% | Perf Quarter | -40.57% |
| Income | -0.01B | P/S | - | EPS this Y | - | Inst Trans | 2.71% | Short Ratio | 0.39 | Perf Half Y | -59.35% |
| Sales | 0.00B | P/B | 0.18 | EPS next 5Y | - | ROA | -40.91% | Short Interest | 0.03M | Perf YTD | -16.06% |
| Book/sh | 3.49 | P/C | 0.18 | EPS past 3/5Y | 67.61% 45.91% | ROE | -46.34% | 52W High | -82% ($3.50) | Perf Year | -62.5% |
| Cash/sh | 3.5 | P/FCF | - | Sales past 3/5Y | - | ROIC | -45.52% | 52W Low | 25.37% ($0.50) | Perf 3Y | -99.25% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 70.71% | Gross Margin | - | Volatility(W/M) | 7.63% 9.08% | Perf 5Y | -99.9% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.05 | Perf 10Y | -99.93% |
| Dividend Ex-Date | - | Quick Ratio | 7.98 | EPS Q/Q | 84.98% | Profit Margin | - | RSI (14) | 47.58 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 7.98 | Sales Q/Q | - | SMA20 | 3.43% ($0.61) | Beta | 0.36 | Target Price | $12 |
| Payout | - | Debt/Eq | 0 | Earnings | 11000000 | SMA50 | -10.07% ($0.7) | Rel Volume | 0.07 | Prev Close | $0.65 |
| Employees | 6 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 38.89% - | SMA200 | -49.49% ($1.25) | Avg Volume(3M) | 0.07M | Price | $0.63 |
| IPO | 2014/3/13 | Option/Short | No/Yes | Trades | 33 | Volume | 5,003 | Change | -3.2% |
뉴스 로딩 중...